Welcome to our dedicated page for Astrotech news (Ticker: ASTC), a resource for investors and traders seeking the latest updates and insights on Astrotech stock.
Astrotech Corporation (Nasdaq: ASTC) is a mass spectrometry company headquartered in Austin, Texas that develops and commercializes technology-driven businesses through its wholly owned subsidiaries. The Astrotech news stream highlights how its core mass spectrometry and gas chromatography technology is being applied in explosives and narcotics trace detection, aviation and cargo security screening, environmental testing, industrial controls, agriculture process analysis, and breath-based VOC analysis related to infections and critical health conditions.
Visitors to this page can review company press releases and other coverage related to Astrotech’s operating milestones. Recent news has described deployments of 1st Detect’s TRACER 1000 explosive and narcotics trace detection systems at airports and cargo facilities, approvals from security authorities for aviation and air cargo screening, and expansion of 1st Detect’s footprint into new regions such as Southeast Asia. Other updates cover the launch and deployment of EN-SCAN environmental testing instruments that integrate gas chromatography and mass spectrometry for real-time air, water, and soil analysis in the field.
Astrotech’s news also addresses corporate and strategic developments, including financial results, participation in investor conferences, executive appointments, and the Board of Directors’ review of strategic alternatives intended to explore options such as equity capital raises, reverse mergers, combination transactions, or potential sales of parts of the business. Investors and analysts following ASTC can use this page to track how the company’s subsidiaries are progressing in markets like security screening, environmental monitoring, industrial manufacturing, and agriculture, as well as to monitor announcements tied to its strategic review and governance activities.
For anyone researching ASTC stock, this news feed offers a centralized view of Astrotech’s operational updates, technology deployments, and capital markets communications over time.
Astrotech (Nasdaq: ASTC) announced on Jan 21, 2026 that subsidiary 1st Detect appointed industry veteran David Spada as Director of Global Sales to expand deployment of the TRACER 1000™ mass spectrometry trace detector in international security markets.
Spada brings over a decade of trace-detection experience from Implant Sciences, Morpho Detection, and Rapiscan Systems and previously led trace-detection sales and strategy for the Americas. The hire aims to accelerate commercial adoption of laboratory-grade, field-deployable molecular identification to reduce false alarms and strengthen screening checkpoints.
Astrotech (Nasdaq: ASTC) said its subsidiary 1st Detect is ready to support the U.S. Department of Homeland Security's $1 billion aviation security modernization initiative announced on Nov 22, 2025. 1st Detect offers the TRACER 1000™ mass spectrometry detection system, approved for TSA air cargo screening and by the European Civil Aviation Conference, and operational at international airports and U.S. cargo facilities.
The company noted TRACER 1000 has not yet been deployed at U.S. passenger checkpoints but said its Austin production facility can scale immediately to meet anticipated demand.
Astrotech Corporation (Nasdaq: ASTC) announced on Nov 19, 2025 that its Board of Directors has initiated a review of strategic alternatives to explore ways to maximize shareholder value. The review may include raising equity capital, reverse mergers, combination transactions, sale of all or part of the business, and other strategic or financial transactions.
The company said it continues to advance sales plans and customer relationships in explosives and narcotics trace detection, security screening, environmental testing and industrial controls. Astrotech has not set a deadline for the review, gave no assurance a transaction will occur, and does not intend further comment unless the Board decides additional disclosure is appropriate.
Astrotech (Nasdaq: ASTC) reported results for Q1 FY2026, quarter ended Sept 30, 2025. Revenue rose to $297,000, a 35% increase versus Q4 FY2025 driven by 1st Detect grant revenue and higher consumables sales. As of Sept 30, 2025, the company has deployed the TRACER 1000 in ~34 locations across 16 countries. The board appointed Nihanth Badugu as COO effective Aug 13, 2025. Consolidated cash and liquid investments totaled $13.9 million, which the company says will support R&D, organic growth, and potential acquisitions. Management highlighted traction in transportation, cargo screening, narcotics and explosives detection, and environmental testing as a platform for sales acceleration in 2026.
Astrotech Corporation (Nasdaq: ASTC) appointed Scott Bartley as Interim Chief Financial Officer, effective October 20, 2025. Bartley is a Certified Public Accountant and Certified Valuation Analyst with over two decades of finance experience across public and private companies and industries including technology, manufacturing, pharmaceuticals and broker‑dealer operations.
His background includes consulting (since 2011), roles at Bridgepoint Consulting, prior CFO positions, ownership of advisory firms, CFO of Westlake Securities (2008–2011), and Assurance Senior Manager at Deloitte & Touche. He holds a BBA and a Master of Professional Accounting from the University of Texas at Austin.
Astrotech (NASDAQ:ASTC) reported its fiscal year 2025 results, showing a decrease in revenue to $1.0 million due to lower device sales at its 1st Detect subsidiary. The company maintained a slight improvement in gross margin at 45.3% compared to 45.1% in the previous year.
Key developments include the formation of EN-SCAN, a new subsidiary for environmental testing, the launch of an enhanced TRACER 1000 Narcotics Trace Detector, and securing a DHS research contract. The TRACER 1000 is now deployed in 34 locations across 16 countries. The company maintains a strong financial position with $18.2 million in cash and investments as of June 30, 2025.
Astrotech Corporation (NASDAQ: ASTC) has appointed Nihanth Badugu as its new Chief Operating Officer, effective August 13, 2025. Badugu, 37, previously served as Astrotech's Director of Program Management since August 2023, where he led initiatives to enhance operational efficiency.
Prior to joining Astrotech, Badugu held positions at Thermo Fisher Scientific as NPI Program Manager (2020-2023), where he led COVID-19 diagnostic products launches, and served as Senior Program Manager at PVA Consulting Group (2017-2020). He holds a Bachelor of Science degree from York University.
Astrotech (NASDAQ: ASTC) has launched its new EN-SCAN product line of portable environmental testing instruments, featuring proprietary ATi Gas Chromatograph Column and Mass Spectrometer Technology. The product lineup includes three solutions: EN-SCAN Rugged-Lab GC-MS, EN-SCAN Fenceline Monitor, and EN-SCAN Handheld GC.
The technology enables real-time environmental monitoring for air, water, and soil analysis, delivering instant results compared to traditional methods that require lab testing and lengthy wait times. EN-SCAN devices come preloaded with thousands of chemical signatures and support applications in environmental compliance, refining, manufacturing, emergency response, and industrial hygiene.
Astrotech (NASDAQ:ASTC) announced its participation in the upcoming H.C. Wainwright 27th Annual Global Investment Conference. The company's leadership team, including Chairman and CEO Thomas B. Pickens III and CFO Jennifer Cañas, will conduct investor meetings on September 9, 2025 at the Lotte New York Palace Hotel in New York City.
Interested investors can schedule meetings through their H.C. Wainwright representative or by contacting Astrotech's Investor Relations directly.
Astrotech Corporation (NASDAQ: ASTC) announced the first sale and deployment of its TRACER 1000™ Narcotics Trace Detector in Vietnam through its subsidiary 1st Detect. This expansion into Southeast Asia represents a strategic milestone in the company's global growth.
The TRACER 1000 NTD™ system, which utilizes Mass Spectrometry technology, provides confirmatory trace narcotics detection with near-zero false alarm rates. CEO Tom Pickens highlighted that the global narcotics and explosives trace detection market is valued at over $7 billion and is experiencing rapid growth due to increasing demand for innovative security solutions.
FAQ
What is the current stock price of Astrotech (ASTC)?
What is the market cap of Astrotech (ASTC)?
